14 Best Multibagger Penny Stocks to Buy Right Now

Page 12 of 13

2. Inventiva S.A. (NASDAQ:IVA)

Share price: $4.46

Analysts upside potential: 300.45%

Number of hedge fund holders: 5

Inventiva S.A. (NASDAQ:IVA) is one of the best multibagger penny stocks to buy right now. Inventiva (NASDAQ:IVA) commands a consensus Buy rating on Wall Street. The average price target for the stock is $17.86, implying 300.45% upside potential.

On November 25, Piper Sandler analyst Yasmeen Rahimi reiterated a Buy rating and a $26 price target. The positive stance comes on the heels of the company generating €4.5 million in revenue for the first nine months of the year, a significant improvement from none for the same period last year.

The clinical-stage biopharmaceutical company had €97.6 million in cash and cash equivalents, a slight improvement from €96.6 million at the end of 2024. In November, it completed a public offering of 44.81 million shares, raising €139.3 million in net proceeds. Under the current cost structure and forecasted expenditures, Inventiva remains in a solid financial position to finance operations through the end of the first quarter of 2027.

Meanwhile, analysts at Guggenheim reiterated a Buy rating on the stock but cut the price target to $11 from $13. The price target cut is in response to the company completing the public offering to finance the NATiV3 Phase 3 trial.

Inventiva S.A. (NASDAQ:IVA) is a clinical-stage biopharmaceutical company focused on the research and development of oral small-molecule therapies for the treatment of patients with MASH. The Company is currently evaluating lanifibranor, a novel pan-PPAR agonist, in the NATiV3 pivotal Phase 3 clinical trial for the treatment of adult patients with MASH, a common and progressive chronic liver disease.

Page 12 of 13